Transcode Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -23 | -4 | -13 | |
EBITDA | -17,529 | -4,845 | -4,263 | |
EBIT | -17,553 | -4,850 | -4,276 | |
Net Income | -17,785 | -13,443 | -4,856 | -4,276 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,978,067 | -8,148 | -4,083 | -4,194 |
Cash | 12,835 | 17,813 | 2,835 | 7,374 |
Basic Shares | 916 | 916 | 833 | 833 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -114 | -534 | -516 | -98 |
EBITDA | -34,314 | -16,193 | -17,973 | -17,466 |
EBIT | -34,428 | -16,728 | -18,490 | -17,564 |
Net Income | -34,661 | -16,754 | -18,546 | -17,564 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,522 | -13,357 | -18,110 | -15,863 |
Cash | 17,813 | 5,811 | 2,767 | 4,968 |
Basic Shares | 689 | 356 | 5 | 16 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$21.27 |
2025-12-31 | -$16.41 |
2025-09-30 | -$5.82 |
2025-06-30 | -$5.13 |